<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1256" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1256/" /><meta name="ncbi_pagename" content="Spinocerebellar Ataxia Type 7 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spinocerebellar Ataxia Type 7 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spinocerebellar Ataxia Type 7" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2012/12/20" /><meta name="citation_author" content="Gwenn Garden" /><meta name="citation_pmid" content="20301433" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1256/" /><meta name="citation_keywords" content="SCA 7" /><meta name="citation_keywords" content="SCA 7" /><meta name="citation_keywords" content="SCA7" /><meta name="citation_keywords" content="Ataxin-7" /><meta name="citation_keywords" content="ATXN7" /><meta name="citation_keywords" content="Spinocerebellar Ataxia Type 7" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spinocerebellar Ataxia Type 7" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Gwenn Garden" /><meta name="DC.Date" content="2012/12/20" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1256/" /><meta name="description" content="Spinocerebellar ataxia type 7 (SCA7) is characterized by progressive cerebellar ataxia, including dysarthria and dysphagia, and cone-rod and retinal dystrophy with progressive central visual loss resulting in blindness in affected adults. Onset in early childhood or infancy has an especially rapid and aggressive course often associated with failure to thrive and regression of motor milestones." /><meta name="og:title" content="Spinocerebellar Ataxia Type 7" /><meta name="og:type" content="book" /><meta name="og:description" content="Spinocerebellar ataxia type 7 (SCA7) is characterized by progressive cerebellar ataxia, including dysarthria and dysphagia, and cone-rod and retinal dystrophy with progressive central visual loss resulting in blindness in affected adults. Onset in early childhood or infancy has an especially rapid and aggressive course often associated with failure to thrive and regression of motor milestones." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1256/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sca7/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1256/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8819D0E041148100000000023800E7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1256_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1256_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca6/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca8/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1256_"><span class="title" itemprop="name">Spinocerebellar Ataxia Type 7</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: SCA 7</div><p class="contrib-group"><span itemprop="author">Gwenn Garden</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1256_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1256_ai__"><div class="contrib half_rhythm"><span itemprop="author">Gwenn Garden</span>, MD, PhD<div class="affiliation small">University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@nedragag" class="oemail">ude.wu@nedragag</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 27, 1998</span>; Last Update: <span itemprop="dateModified">December 20, 2012</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sca7.Summary" itemprop="description"><h2 id="_sca7_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spinocerebellar ataxia type 7 (SCA7) is characterized by progressive cerebellar ataxia, including dysarthria and dysphagia, and cone-rod and retinal dystrophy with progressive central visual loss resulting in blindness in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults. Onset in early childhood or infancy has an especially rapid and aggressive course often associated with failure to thrive and regression of motor milestones.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SCA7 is suspected in most adults based on clinical findings. <i>ATXN7</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants cause SCA7. Molecular genetic testing to detect an abnormal CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansion in <i>ATXN7</i> is used to confirm the diagnosis of SCA7 in adults and to establish the diagnosis in children. Affected individuals usually have greater than 36 CAG repeats, although individuals with fewer repeats may also present with symptoms.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: For adults: use of canes and walkers to prevent falls, home modifications (e.g., grab bars, raised toilet seats, and ramps) for mobility, weighted eating utensils and dressing hooks for independence, speech therapy and communication devices for those with dysarthria, and feeding assessment for those with dysphagia; low-vision aids and mobility training for those with visual impairment.</p><p><i>Prevention of secondary complications</i>: Weight control to facilitate ambulation and mobility.</p><p><i>Surveillanc</i>e: Routine ophthalmologic examination.</p><p><i>Other</i>: Tremor-controlling drugs are ineffective.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SCA7 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Offspring of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a 50% chance of inheriting the altered <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Anticipation, resulting from further expansion of the CAG repeat on transmission from parent to child, occurs. Prenatal testing is possible for pregnancies at increased risk once the diagnosis has been confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> in an affected family member.</p></div></div><div id="sca7.Diagnosis"><h2 id="_sca7_Diagnosis_">Diagnosis</h2><div id="sca7.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Although formal diagnostic criteria have not been established, the diagnosis of spinocerebellar ataxia type 7 (SCA7) can be established in adults who have the following findings:</p><ul><li class="half_rhythm"><div>Progressive incoordination caused by cerebellar ataxia, including dysarthria/dysphagia, dysmetria, and dysdiadochokinesia</div></li><li class="half_rhythm"><div>Cone-rod retinal dystrophy with the following:</div><ul><li class="half_rhythm"><div>Abnormalities of rod and cone function on electroretinogram testing</div></li><li class="half_rhythm"><div>A tritan-axis (blue/yellow) defect on detailed color vision testing</div></li><li class="half_rhythm"><div>Macular changes on fundoscopic examination (late in the disease course)</div></li></ul></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div></li></ul><p>In children, the disease progression is often more rapid and aggressive than in adults. In infants, clinical diagnosis may be difficult because ataxia and visual loss are not obvious; failure to thrive and loss of motor milestones may be the earliest findings [<a class="bk_pop" href="#sca7.REF.benton.1998.1081">Benton et al 1998</a>].</p></div><div id="sca7.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>ATXN7</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is known to cause spinocerebellar ataxia type 7 (SCA7).</p><p><b>Allele sizes</b></p><ul><li class="half_rhythm"><div><b>Normal alleles.</b> Approximately 75% of normal alleles have ten CAG repeats [<a class="bk_pop" href="#sca7.REF.michalik.2004.2">Michalik et al 2004</a>]. To date, no normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with greater than 19 CAG repeats has been reported. Thus, no data regarding the significance of alleles between 19 and 27 CAG repeats are available.</div></li><li class="half_rhythm"><div><b>Alleles of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>.</b> Whether alleles with 28-36 repeats are mutable normal alleles or alleles with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> awaits long-term clinical follow up of individuals with this number of repeats [<a class="bk_pop" href="#sca7.REF.stevanin.1998.1809">Stevanin et al 1998</a>].</div></li><li class="half_rhythm"><div><b>Mutable normal alleles.</b> 28 to 33 CAG repeats [<a class="bk_pop" href="#sca7.REF.lebre.2003">Lebre et al 2003</a>]. Previously called "intermediate alleles," mutable normal alleles are meiotically unstable and not convincingly associated with an abnormal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Because of the instability of alleles in the mutable normal range, an asymptomatic individual with a mutable normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may be predisposed to having a child with an expanded allele [<a class="bk_pop" href="#sca7.REF.mittal.2005.155">Mittal et al 2005</a>].</div></li><li class="half_rhythm"><div><b>Reduced-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> alleles.</b> 34-36 CAG repeats may be provisionally defined as alleles with reduced penetrance (i.e., variably associated with disease manifestations). When they occur, symptoms are more likely to be later in onset and milder than average.</div><ul><li class="half_rhythm"><div>A woman with 34 CAG repeats had "very mild symptoms" at age 65 years [<a class="bk_pop" href="#sca7.REF.nardacchione.1999.232">Nardacchione et al 1999</a>].</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#sca7.REF.koob.1998.72">Koob et al [1998]</a> described a symptomatic individual with 35 CAG repeats, in contrast to the asymptomatic adults with 35 CAG repeats described by <a class="bk_pop" href="#sca7.REF.david.1998.165">David et al [1998]</a> and <a class="bk_pop" href="#sca7.REF.stevanin.1998.1809">Stevanin et al [1998]</a>.</div></li><li class="half_rhythm"><div>An individual with 36 CAG repeats developed relatively mild symptoms at age 63 years [<a class="bk_pop" href="#sca7.REF.nardacchione.1999.232">Nardacchione et al 1999</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Full-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> alleles.</b> Alleles of greater than 36 CAG repeats [<a class="bk_pop" href="#sca7.REF.nardacchione.1999.232">Nardacchione et al 1999</a>, <a class="bk_pop" href="#sca7.REF.michalik.2004.2">Michalik et al 2004</a>] to extreme expansions, e.g., 460 CAG repeats [<a class="bk_pop" href="#sca7.REF.van_de_warrenburg.2001.911">van de Warrenburg et al 2001</a>] are considered fully penetrant.</div></li></ul><p>Note: The distinction between the <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> size for reduced-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> alleles and for full-penetrance alleles is likely to remain unclear until more families are reported; nonetheless, regardless of the "descriptor" used for these alleles, they should be considered unstable and pathogenic.</p><p><b>Targeted analysis for pathogenic variants</b></p><ul><li class="half_rhythm"><div><b><a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> analysis</b> may be used to detect <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansions in the first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> of <i>ATXN7</i> that are up to approximately 100 repeats [<a class="bk_pop" href="#sca7.REF.fu.1991.1047">Fu et al 1991</a>]. PCR analysis may show either two <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> normal-sized alleles or a single normal-sized <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. In the latter case, it may be necessary to perform Southern analysis to determine if the two alleles are the same size and within normal range or if one of the alleles is expanded and therefore not detectable by the PCR analysis.</div></li><li class="half_rhythm"><div><b>Southern analysis</b> may be necessary to detect repeat expansions of more than approximately 100 CAG repeats.</div></li></ul><div id="sca7.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in the Diagnosis of SCA7</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1256/table/sca7.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca7.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATXN7</i></td><td headers="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants: <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> amplification</td><td headers="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansions of &#x02264;~100 repeats</td><td headers="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td></tr><tr><td headers="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants: Southern analysis</td><td headers="hd_h_sca7.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Highly expanded CAG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansions (&#x0003e;100 repeats)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sca7.TF.1.1"><p class="no_margin">See <a href="/books/NBK1256/#sca7.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sca7.TF.1.2"><p class="no_margin">See <a href="#sca7.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="sca7.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd></dl></div></div></div></div><div id="sca7.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Use <a class="def" href="/books/n/gene/glossary/def-item/targeted-analysis-for-pathogenic-variants/">targeted analysis for pathogenic variants</a> to determine the number of CAG trinucleotide repeats.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If a single normal-sized <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is identified, determine if there is a family history of SCA7 and/or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> cerebellar ataxia with retinal degeneration. Based on the family history and the age of onset in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, determine if <a class="def" href="/books/n/gene/glossary/def-item/southern-blot/">Southern blot</a> analysis to detect very large <i>ATXN7</i> CAG repeat expansions is appropriate for the proband or another family member.</p></dd></dl></div></div><div id="sca7.Clinical_Characteristics"><h2 id="_sca7_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sca7.Clinical_Description"><h3>Clinical Description</h3><p>The onset of spinocerebellar ataxia type 7 (SCA7) ranges from infancy (with an accelerated course and early death) to the fifth or occasionally sixth decade (with slowly progressive retinal degeneration and cerebellar ataxia) [<a class="bk_pop" href="#sca7.REF.giunti.1999.1594">Giunti et al 1999</a>].</p><p><b>In infancy or early childhood</b>, ataxia may not be obvious but muscle wasting, weakness, and hypotonia are common [<a class="bk_pop" href="#sca7.REF.enevoldson.1994.445">Enevoldson et al 1994</a>]. Two infants with severe disease and expansions of more than 200 and 306 CAG repeats had neonatal hypotonia, developmental delay, poor feeding, dysphagia, congestive heart failure, cerebral and cerebellar atrophy, and retinal disease [<a class="bk_pop" href="#sca7.REF.babovicvuksanovic.1998.383">Babovic-Vuksanovic et al 1998</a>, <a class="bk_pop" href="#sca7.REF.benton.1998.1081">Benton et al 1998</a>]. <a class="bk_pop" href="#sca7.REF.ansorge.2004.448">Ansorge et al [2004]</a> reported a child with 180 CAG repeats dying in infancy.</p><p>In those with infantile-onset disease, the cerebellar and brain stem degeneration is so rapid that retinal degeneration and related vision loss may not be evident.</p><p>When initial symptoms occur at or before adolescence, blindness from retinal degeneration can occur within a few years. Individuals showing symptoms in their teens may be blind within a decade or less.</p><p><b>In adults,</b> the progressive cerebellar ataxia (i.e., dysmetria, dysdiadochokinesia, and poor coordination) may precede, but usually follows, the onset of visual symptoms. While the rate of progression varies, the eventual result is severe dysarthria, dysphagia, and a bedridden state with loss of motor control.</p><p>Brisk tendon reflexes and spasticity become evident as the disease progresses. Ocular saccades may become markedly slowed.</p><p>Cognitive decline and psychosis have been reported [<a class="bk_pop" href="#sca7.REF.benton.1998.1081">Benton et al 1998</a>]. Neuropsychiatric testing of some individuals with SCA7 has revealed selective deficits in social cognition [<a class="bk_pop" href="#sca7.REF.sokolovsky.2010.17">Sokolovsky et al 2010</a>].</p><p>The retinal degeneration is a progressive, cone-rod dystrophy that results in total blindness [<a class="bk_pop" href="#sca7.REF.to.1993.15">To et al 1993</a>, <a class="bk_pop" href="#sca7.REF.aleman.2002.737">Aleman et al 2002</a>, <a class="bk_pop" href="#sca7.REF.ahn.2005.923">Ahn et al 2005</a>, <a class="bk_pop" href="#sca7.REF.hugosson.2009.1">Hugosson et al 2009</a>]. The onset of retinal degeneration is often characterized in the late teens or early 20s by hemeralopia (inability to see clearly in bright light), photophobia (extreme sensitivity to light), and abnormalities in color vision and central visual acuity [<a class="bk_pop" href="#sca7.REF.miller.2009.180">Miller et al 2009</a>].</p><p>During the earliest stages of retinal degeneration, young adults may have no symptoms, but may have subtle granular changes in the macula and make errors in the tritan (blue-yellow) axis on detailed color vision testing using the Farnsworth dichromatous (D15) test. Electroretinogram is consistently abnormal early in the disease course, showing a decrease in the photopic (cone) response initially, followed by a decrease in the scotopic (rod) response [<a class="bk_pop" href="#sca7.REF.miller.2009.180">Miller et al 2009</a>].</p><p>As cone function decreases over time, central visual acuity decreases to the 20/200 (legally blind) range, more prominent macular changes appear (see <a class="figpopup" href="/books/NBK1256/figure/sca7.F1/?report=objectonly" target="object" rid-figpopup="figsca7F1" rid-ob="figobsca7F1">Figure 1</a>), all color discrimination is lost, and eventually all vision.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsca7F1" co-legend-rid="figlgndsca7F1"><a href="/books/NBK1256/figure/sca7.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figsca7F1" rid-ob="figobsca7F1"><img class="small-thumb" src="/books/NBK1256/bin/sca7-Image001.gif" src-large="/books/NBK1256/bin/sca7-Image001.jpg" alt="Figure 1. . Funduscopic photo shows extreme macular degeneration of late-stage SCA7." /></a><div class="icnblk_cntnt" id="figlgndsca7F1"><h4 id="sca7.F1"><a href="/books/NBK1256/figure/sca7.F1/?report=objectonly" target="object" rid-ob="figobsca7F1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Funduscopic photo shows extreme macular degeneration of late-stage SCA7. </p></div></div><p>It is important to note that in adult-onset disease visual loss from retinal degeneration may precede, accompany, or follow the onset of ataxia [<a class="bk_pop" href="#sca7.REF.miller.2009.180">Miller et al 2009</a>] and that profound visual loss can be accompanied by minimal ophthalmoscopic findings and minimal ataxia [<a class="bk_pop" href="#sca7.REF.thurtell.2009.187">Thurtell et al 2009</a>].</p><p><b>Pathology.</b> Neuronal loss, loss of myelinated fibers, and gliosis are observed in the cerebellum (especially Purkinje cells); inferior olivary, dentate, and pontine nuclei; and to a lesser extent in cerebral cortex, basal ganglia, thalamus and midbrain [<a class="bk_pop" href="#sca7.REF.r_b.2008.155">R&#x000fc;b et al 2008</a>, <a class="bk_pop" href="#sca7.REF.seidel.2012.1">Seidel et al 2012</a>].</p><p>In a detailed pathoanatomical study, <a class="bk_pop" href="#sca7.REF.r_b.2008.155">R&#x000fc;b et al [2008]</a> correlated the widespread pattern of brain neuronal degeneration with the variable clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, comparing degeneration in 18 different regions with various clinical manifestations such as ataxia, pyramidal signs, visual loss, diplopia, and impaired hearing.</p><p>Nuclear inclusion aggregates, containing mutated ataxin-7 in neurons from both degenerating and spared areas, are largely absent from Purkinje cells [<a class="bk_pop" href="#sca7.REF.michalik.2003.r173">Michalik &#x00026; Van Broeckhoven 2003</a>]. In a severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant, <a class="bk_pop" href="#sca7.REF.ansorge.2004.448">Ansorge et al [2004]</a> identified ataxin-7 nuclear inclusions in the hippocampus and many non-nervous system tissues including the intestine, pancreas, and cardiovascular system. Abnormal mitochondria have also been observed in biopsies from skeletal muscle and liver [<a class="bk_pop" href="#sca7.REF.han.2010a.622">Han et al 2010a</a>].</p><p>Degeneration is evident in the posterior columns and spinocerebellar tracks of the spinal cord [<a class="bk_pop" href="#sca7.REF.martin.1994.277">Martin et al 1994</a>, <a class="bk_pop" href="#sca7.REF.lebre.2003">Lebre et al 2003</a>, <a class="bk_pop" href="#sca7.REF.koeppen.2005.62">Koeppen 2005</a>].</p><p>Degeneration of photoreceptors and bipolar and granular cells is evident in the retina, especially in the foveal and parafoveal regions [<a class="bk_pop" href="#sca7.REF.martin.1994.277">Martin et al 1994</a>].</p></div><div id="sca7.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>A correlation between CAG repeat length and disease severity exists: the longer the CAG repeat, the earlier the age of onset and the more severe and rapidly progressive the disease. Despite observations correlating CAG repeat length with age of onset, disease severity, and course, current consensus is that <i>ATXN7</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> size cannot provide sufficient predictive value for clinical prognosis [<a class="bk_pop" href="#sca7.REF.andrew.1997.2005">Andrew et al 1997</a>].</p></div><div id="sca7.Penetrance"><h3>Penetrance</h3><p>See <a href="#sca7.Molecular_Genetic_Testing">Molecular Genetic Testing</a>.</p></div><div id="sca7.Anticipation"><h3>Anticipation</h3><p>In families with a disease-causing <i>ATXN7</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, repeat length tends to expand with transmission to successive generations, with more marked expansions seen in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring of affected males [<a class="bk_pop" href="#sca7.REF.gouw.1998.525">Gouw et al 1998</a>]. This explains, at the genetic level, the marked <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> seen in families with SCA7, now regarded as the most unstable of the disorders with CAG repeats. Anticipation in a family may be so dramatic that a child may be diagnosed with what is thought to be a <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> neurodegenerative disease years before a parent or grandparent with an <i>ATXN7</i> CAG repeat expansion becomes symptomatic [<a class="bk_pop" href="#sca7.REF.van_de_warrenburg.2001.911">van de Warrenburg et al 2001</a>, <a class="bk_pop" href="#sca7.REF.ansorge.2004.448">Ansorge et al 2004</a>].</p></div><div id="sca7.Nomenclature"><h3>Nomenclature</h3><p>The association of retinal degeneration with cerebellar ataxia has been recognized for many decades [<a class="bk_pop" href="#sca7.REF.havener.1951.40">Havener 1951</a>, <a class="bk_pop" href="#sca7.REF.carpenter.1966.82">Carpenter &#x00026; Schumacher 1966</a>, <a class="bk_pop" href="#sca7.REF.weiner.1967.364">Weiner et al 1967</a>, <a class="bk_pop" href="#sca7.REF.konigsmark.1970.227">Konigsmark &#x00026; Weiner 1970</a>, <a class="bk_pop" href="#sca7.REF.anttinen.1986.180">Anttinen et al 1986</a>, <a class="bk_pop" href="#sca7.REF.gouw.1994.1441">Gouw et al 1994</a>]. Terms used in the past to designate SCA7 include olivopontocerebellar ataxia (OPCA) type III and OPCA type II.</p></div><div id="sca7.Prevalence"><h3>Prevalence</h3><p>The prevalence is less than 1:100,000 population. In several studies, SCA7 represented 2% of all SCAs [<a class="bk_pop" href="#sca7.REF.filla.2000.31">Filla et al 2000</a>, <a class="bk_pop" href="#sca7.REF.storey.2000.351">Storey et al 2000</a>].</p><p>No individuals with SCA7 were reported from population studies in Hokkaido, Japan [<a class="bk_pop" href="#sca7.REF.sasaki.2000.45">Sasaki et al 2000</a>, <a class="bk_pop" href="#sca7.REF.jardim.2001.870">Jardim et al 2001</a>, <a class="bk_pop" href="#sca7.REF.kim.2001.336">Kim et al 2001</a>] and mainland China [<a class="bk_pop" href="#sca7.REF.tang.2000.540">Tang et al 2000</a>]. However, another study reported four families with SCA7 from Beijing, China [<a class="bk_pop" href="#sca7.REF.gu.2000.1513">Gu et al 2000</a>] and one from Taiwan [<a class="bk_pop" href="#sca7.REF.tsai.2004.355">Tsai et al 2004</a>]. <a class="bk_pop" href="#sca7.REF.han.2010b.2274">Han et al [2010b]</a> reviewed seven reports describing 14 families with SCA7 in Southeast Asia (3 from mainland China, 1 from Taiwan, 2 from Japan, and 8 from Korea). The clinical and genetic features of these families were typical of SCA7 in Western countries.</p></div></div><div id="sca7.Genetically_Related_Allelic_Disorde"><h2 id="_sca7_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those described in this <i>GeneReview</i> chapter have been associated with pathogenic variants in <i>ATXN7</i>.</p></div><div id="sca7.Differential_Diagnosis"><h2 id="_sca7_Differential_Diagnosis_">Differential Diagnosis</h2><p>While many of the clinical and pathologic findings of the other spinocerebellar ataxias (SCAs) overlap with SCA7, retinal degeneration is the distinguishing feature of SCA7 (see <a href="/books/n/gene/ataxias/">Ataxia Overview</a>).</p><p>A few individuals with <a href="/books/n/gene/sca1/">SCA1</a> have been reported to have progressive visual loss [<a class="bk_pop" href="#sca7.REF.illarioshkin.1996.506">Illarioshkin et al 1996</a>, <a class="bk_pop" href="#sca7.REF.abe.1997.231">Abe et al 1997</a>].</p><p>The SCA7 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may be confused with acquired ataxia associated with other forms of visual loss such as diabetic retinopathy, multiple sclerosis, or age-related macular degeneration.</p><p>Mitochondrial encephalopathies such as <a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a> (LHON) can present with ataxia and, in some cases, concomitant visual degeneration; these mitochondrially based ataxias can be distinguished from SCA7 by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, by pattern of inheritance (maternal inheritance rather than <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance), and by the absence of <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a>, which is normally seen in SCA7 (see <a href="/books/n/gene/mt-overview/">Mitochondrial Diseases Overview</a>).</p><p>Infantile and childhood-onset SCA7 may be confused with lipid storage diseases and the neuronal ceroid-lipofuscinoses.</p></div><div id="sca7.Management"><h2 id="_sca7_Management_">Management</h2><div id="sca7.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with spinocerebellar ataxia type 7 (SCA7), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Medical history</div></li><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Ophthalmologic examination including assessment of visual acuity, visual fields, and color vision</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sca7.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals remains supportive as no known therapy to delay or halt the progression of the disease exists.</p><p><b>Cerebellar ataxia</b>. Although neither exercise nor physical therapy has been shown to stem the progression of incoordination or muscle weakness, individuals with spinocerebellar ataxia type 7 (SCA7) should maintain activity. Canes and walkers help prevent falls.</p><p>Modification of the home with such conveniences as grab bars, raised toilet seats, and ramps to accommodate motorized chairs may be necessary.</p><p>Speech therapy and communication devices such as writing pads and computer-based devices may benefit those with dysarthria.</p><p>Weighted eating utensils and dressing hooks help maintain a sense of independence.</p><p>When dysphagia becomes troublesome, video esophagrams can identify the consistency of food least likely to trigger aspiration.</p><p>Note: Tremor-controlling drugs do not work well for cerebellar tremors.</p><p><b>Retinal degeneration</b>. Use of sunglasses and limitation of UV exposure are encouraged in order to limit damage to the retina.</p><p>Various optical aids have been proposed for individuals with peripheral visual loss and preserved central vision, although all have drawbacks.</p><p>Low vision aids such as magnifiers and closed circuit television may provide useful reading vision for individuals with reduced central acuity and constricted visual fields.</p><p>Wide-field, high-intensity flashlights produce a bright wide beam of light and improve the nighttime mobility of individuals with retinal degeneration. They are inexpensive and allow binocular viewing, but are large, heavy, and conspicuous.</p></div><div id="sca7.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>No dietary factor has been shown to curtail symptoms; however, vitamin supplements are recommended, particularly if caloric intake is reduced.</p><p>Weight control is important because obesity can exacerbate difficulties with ambulation and mobility.</p></div><div id="sca7.Surveillance"><h3>Surveillance</h3><p>Routine follow up by an ophthalmologist is appropriate to measure visual acuity and visual fields and to help identify appropriate visual aids.</p></div><div id="sca7.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sca7.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p><p><b>Pregnancy Management</b></p><p>Walking during pregnancy may be more difficult than usual because of the ataxia.</p></div><div id="sca7.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><a class="bk_pop" href="#sca7.REF.scholefield.2009.e7232">Scholefield et al [2009]</a> have suggested <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>-specific RNA interference as a therapeutic approach for SCA7.</p><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sca7.Genetic_Counseling"><h2 id="_sca7_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sca7.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spinocerebellar ataxia type 7 (SCA7) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="sca7.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed as having SCA7 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with SCA7 may have the disorder as the result of expansion of a <a class="def" href="/books/n/gene/glossary/def-item/reduced-penetrance-allele/">reduced-penetrance allele</a> (34-36 CAG repeats) or a mutable normal allele (28-33 CAG repeats) inherited from an unaffected parent.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include clinical evaluation and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>ATXN7</i>.</div></li></ul><p>Note: Although most individuals diagnosed with SCA7 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> person depends on the genetic status of the parents: if one parent has an expanded <i>ATXN7</i> CAG repeat, the risk to each sib of inheriting the expanded CAG repeat is 50%.</div></li><li class="half_rhythm"><div>The risk to the individual who inherits an expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> of developing the SCA7 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> depends on the size of the CAG repeat.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 50% chance of inheriting the expanded CAG repeat at conception. The risk to the individual who inherits an expanded CAG repeat of developing the SCA7 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> depends on the size of the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parent: if a parent has an expanded CAG repeat, his or her family members are at risk.</p></div><div id="sca7.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>At-risk individuals.</b> The age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be predicted by the family history or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Testing of at-risk asymptomatic individuals.</b> Testing of at-risk adults for SCA7 is possible using the techniques described in <a href="#sca7.Molecular_Genetic_Testing">Molecular Genetic Testing</a>. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. When testing at-risk individuals for SCA7, an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member should be tested first to confirm the molecular diagnosis. <b>It should be remembered that testing for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the absence of definite symptoms of the disease is predictive testing.</b> At-risk asymptomatic adult family members may seek testing in order to make personal decisions regarding reproduction, financial matters, and career planning. Others may have different motivations including simply "the need to know." Testing of asymptomatic at-risk adult family members usually involves pre-test interviews in which the motives for requesting the test, the individual's knowledge of SCA7, the possible impact of positive and negative test results, and neurologic status are assessed. Those seeking testing should be counseled about possible problems that they may encounter with regard to health, life, and disability insurance coverage, employment and educational discrimination, and changes in social and family interaction. Other issues to consider are implications for the at-risk status of other family members. Informed consent should be procured and records kept confidential. Individuals with positive test results need arrangements for long-term follow up and evaluations.</p><p><b>Testing of at-risk individuals younger than age 18 years.</b> Consensus holds that individuals younger than age 18 years who are at risk for adult-onset disorders should not have testing in the absence of symptoms. The principal arguments against testing asymptomatic individuals younger than age 18 years are that it removes their choice to know or not know this information, it raises the possibility of stigmatization within the family and in other social settings, and it could have serious educational and career implications [<a class="bk_pop" href="#sca7.REF.bloch.1990.1">Bloch &#x00026; Hayden 1990</a>, <a class="bk_pop" href="#sca7.REF.harper.1990.1205">Harper &#x00026; Clarke 1990</a>]. Individuals younger than age 18 years who are symptomatic usually benefit from having a specific diagnosis established. See also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sca7.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the expanded <i>ATXN7</i> CAG repeat has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for SCA7 are possible.</p></div></div><div id="sca7.Resources"><h2 id="_sca7_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22234/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spinocerebellar ataxia</a></div></li><li class="half_rhythm"><div><b>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</b></div><div><i>Booklet providing information about Spinocerebellar Ataxia</i></div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf</a></div></li><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>Spanish Ataxia Federation (FEDAES)</b></div><div>Spain</div><div><b>Phone:</b> 34 983 278 029; 34 985 097 152; 34 634 597 503</div><div><b>Email:</b> sede.valladolid@fedaes.org; sede.gijon@fedaes.org; sede.bilbao@fedaes.org</div><div><a href="http://www.fedaes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fedaes.org</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="sca7.Molecular_Genetics"><h2 id="_sca7_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sca7.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spinocerebellar Ataxia Type 7: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1256/table/sca7.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca7.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sca7.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sca7.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sca7.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sca7.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sca7.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sca7.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sca7.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6314" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ATXN7</i></a></td><td headers="hd_b_sca7.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6314" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p14<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_sca7.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15265" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ataxin-7</a></td><td headers="hd_b_sca7.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ATXN7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN7 database</a></td><td headers="hd_b_sca7.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATXN7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN7</a></td><td headers="hd_b_sca7.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ATXN7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN7</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sca7.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sca7.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spinocerebellar Ataxia Type 7 (<a href="/omim/164500,607640" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1256/table/sca7.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca7.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/164500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">164500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA 7; SCA7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607640" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607640</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATAXIN 7; ATXN7</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>ATXN7</i> is 136,094 bp in length encoding an 892-amino acid protein. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1256/#sca7.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> A polymorphic CAG repeat tract occurs in the first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>; normal alleles have between four and 19 CAG repeats. In unaffected, unrelated reference populations, (CAG)<sub>10</sub> was the most common <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and alleles larger than 19 repeats were not observed [<a class="bk_pop" href="#sca7.REF.delfavero.1998.177">Del-Favero et al 1998</a>, <a class="bk_pop" href="#sca7.REF.gouw.1998.525">Gouw et al 1998</a>]. Splice variants appear to exist, although their significance is unknown.</p><p><b>Pathogenic variants.</b> The <i>ATXN7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is an abnormal (CAG)<sub>n</sub> <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansion in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of the protein [<a class="bk_pop" href="#sca7.REF.david.1997.65">David et al 1997</a>]. Pathogenic alleles range from 36 to more than 450 CAG repeats [<a class="bk_pop" href="#sca7.REF.michalik.2004.2">Michalik et al 2004</a>]. Alleles with 28-36 CAG repeats are of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> (see <a href="#sca7.Molecular_Genetic_Testing">Molecular Genetic Testing</a>).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Ataxin-7, the gene product of <i>ATXN7,</i> is expected to be about 95 kd. The protein is predominantly nuclear, but shuttles between the nucleus and cytoplasm. One function of ataxin-7 is as a core component of a transcription co-activator complex called STAGA [Garden &#x00026; LaSpada 2008]. Ataxin-7 also has a cytoplasmic role in stabilizing microtubules [<a class="bk_pop" href="#sca7.REF.nakamura.2012.1099">Nakamura et al 2012</a>]. The normal distribution of ataxin-7 in human brain and retina has been described [<a class="bk_pop" href="#sca7.REF.cancel.2000.2519">Cancel et al 2000</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The CAG repeats in <i>ATXN7</i> code for a run of glutamines. In unaffected individuals, the polyglutamine tract is from four to 19 amino acids long. Abnormal proteins have an expanded polyglutamine tract of 37 or more amino acids. Protein from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been detected in the nuclear fraction and appears to run at approximately 130 kd [<a class="bk_pop" href="#sca7.REF.trottier.1995.403">Trottier et al 1995</a>]. CAG repeat expansions in <i>ATXN7</i> suppress transcription of an antisense noncoding RNA that promotes repressive chromatin modification of the ataxin-7 promoter [<a class="bk_pop" href="#sca7.REF.sopher.2011.1071">Sopher et al 2011</a>], leading to increased expression of the mutated protein.</p><p>The precise molecular mechanism by which mutated ataxin-7 causes neurodegeneration is not well defined. In a cell culture model, <a class="bk_pop" href="#sca7.REF.ajayi.2012.86">Ajayi et al [2012]</a> report that mutated ataxin-7 leads to increased production of reactive oxygen species, which contribute to toxicity. Both <a class="bk_pop" href="#sca7.REF.mookerjee.2009.15134">Mookerjee et al [2009]</a> and <a class="bk_pop" href="#sca7.REF.janer.2010.181">Janer et al [2010]</a> noted that post-translational modification of lysine 257 in ataxin-7 is important in pathogenesis.</p><p>In an SCA7 transgenic mouse model, expanded polyglutamine tracts induce neurodegeneration and transneuronal alterations in cerebellum and retina [<a class="bk_pop" href="#sca7.REF.yvert.2000.2491">Yvert et al 2000</a>]. Deletion of Gcn5, an enzymatic component of the STAGA complex, worsens cerebellar and retinal pathology [<a class="bk_pop" href="#sca7.REF.chen.2012.394">Chen et al 2012</a>]. Abnormal Bergmann glia in the cerebellum may cause degeneration by way of impaired glutamate transport resulting in non-cell autonomous degeneration of cerebellar Purkinje cells [<a class="bk_pop" href="#sca7.REF.garden.2002.4897">Garden et al 2002</a>, <a class="bk_pop" href="#sca7.REF.custer.2006.1302">Custer et al 2006</a>]. Neurons in the inferior olive that project climbing fibers to the cerebellum also appear to play a role in SCA7 pathogenesis. Deletion of the mutated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from three cell types &#x02013; Bergmann glia, inferior olive neurons, and Purkinje cells &#x02013; doubled the presymptomatic period in transgenic mice [<a class="bk_pop" href="#sca7.REF.furrer.2011.16269">Furrer et al 2011</a>]. Suppression of mutated protein expression by 50% in transgenic mice reverses several aspects of the mouse SCA7 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, suggesting avenues for potential therapy [<a class="bk_pop" href="#sca7.REF.furrer.2013.890">Furrer et al 2013</a>].</p></div><div id="sca7.References"><h2 id="_sca7_References_">References</h2><div id="sca7.Published_Guidelines__Consensus_Sta"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca7.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 3-29-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 3-29-19.</div></li></ul></div><div id="sca7.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.abe.1997.231">Abe T, Abe K, Aoki M, Itoyama Y, Tamai M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. <span><span class="ref-journal">Arch Ophthalmol. </span>1997;<span class="ref-vol">115</span>:231–6.</span> [<a href="/pubmed/9046258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9046258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.ahn.2005.923">Ahn JK, Seo JM, Chung H, Yu HG. Anatomical and functional characteristics in atrophic maculopathy associated with spinocerebellar ataxia type 7. <span><span class="ref-journal">Am J Ophthalmol. </span>2005;<span class="ref-vol">139</span>:923–5.</span> [<a href="/pubmed/15860307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15860307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.ajayi.2012.86">Ajayi A, Yu X, Lindberg S, Langel U, Str&#x000f6;m AL. Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model. <span><span class="ref-journal">BMC Neurosci. </span>2012;<span class="ref-vol">13</span>:86.</span> [<a href="/pmc/articles/PMC3412756/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3412756</span></a>] [<a href="/pubmed/22827889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22827889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.aleman.2002.737">Aleman TS, Cideciyan AV, Volpe NJ, Stevanin G, Brice A, Jacobson SG. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype. <span><span class="ref-journal">Exp Eye Res. </span>2002;<span class="ref-vol">74</span>:737–45.</span> [<a href="/pubmed/12126946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12126946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.andrew.1997.2005">Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:2005–10.</span> [<a href="/pubmed/9328463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9328463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.ansorge.2004.448">Ansorge O, Giunti P, Michalik A, Van Broeckhoven C, Harding B, Wood N, Scaravilli F. Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats. <span><span class="ref-journal">Ann Neurol. </span>2004;<span class="ref-vol">56</span>:448–52.</span> [<a href="/pubmed/15349877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15349877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.anttinen.1986.180">Anttinen A, Nikoskelainen E, Marttila RJ, Grenman R, Falck B, Aarnisalo E, Kalimo H. Familial olivopontocerebellar atrophy with macular degeneration: a separate entity among the olivopontocerebellar atrophies. <span><span class="ref-journal">Acta Neurol Scand. </span>1986;<span class="ref-vol">73</span>:180–90.</span> [<a href="/pubmed/3705927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3705927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.babovicvuksanovic.1998.383">Babovic-Vuksanovic D, Snow K, Patterson MC, Michels VV. Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">79</span>:383–7.</span> [<a href="/pubmed/9779806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9779806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.benton.1998.1081">Benton CS, de Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">51</span>:1081–6.</span> [<a href="/pubmed/9781533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9781533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.bloch.1990.1">Bloch M, Hayden MR. Opinion: predictive testing for Huntington disease in childhood: challenges and implications. <span><span class="ref-journal">Am J Hum Genet. </span>1990;<span class="ref-vol">46</span>:1–4.</span> [<a href="/pmc/articles/PMC1683548/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1683548</span></a>] [<a href="/pubmed/2136787" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2136787</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.cancel.2000.2519">Cancel G, Duyckaerts C, Holmberg M, Zander C, Yvert G, Lebre AS, Ruberg M, Faucheux B, Agid Y, Hirsch E, Brice A. Distribution of ataxin-7 in normal human brain and retina. <span><span class="ref-journal">Brain. </span>2000;<span class="ref-vol">123</span>:2519–30.</span> [<a href="/pubmed/11099453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11099453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.carpenter.1966.82">Carpenter S, Schumacher GA. Familial infantile cerebellar atrophy associated with retinal degeneration. <span><span class="ref-journal">Arch Neurol. </span>1966;<span class="ref-vol">14</span>:82–94.</span> [<a href="/pubmed/5900234" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5900234</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.chen.2012.394">Chen YC, Gatchel JR, Lewis RW, Mao CA, Grant PA, Zoghbi HY, Dent SY. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:394–405.</span> [<a href="/pmc/articles/PMC3276287/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3276287</span></a>] [<a href="/pubmed/22002997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22002997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.custer.2006.1302">Custer SK, Garden GA, Gill N, Rueb U, Libby RT, Schultz C, Guyenet SJ, Deller T, Westrum LE, Sopher BL, La Spada AR. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. <span><span class="ref-journal">Nat Neurosci. </span>2006;<span class="ref-vol">9</span>:1302–11.</span> [<a href="/pubmed/16936724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16936724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.david.1997.65">David G, Abbas N, Stevanin G, D&#x000fc;rr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel JL, Brice A. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:65–70.</span> [<a href="/pubmed/9288099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9288099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.david.1998.165">David G, D&#x000fc;rr A, Stevanin G, Cancel G, Abbas N, Benomar A, Belal S, Lebre AS, Abada-Bendib M, Grid D, Holmberg M, Yahyaoui M, Hentati F, Chkili T, Agid Y, Brice A. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:165–70.</span> [<a href="/pubmed/9425222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.delfavero.1998.177">Del-Favero J, Krols L, Michalik A, Theuns J, L&#x000f6;fgren A, Goossens D, Wehnert A, Van den Bossche D, Van Zand K, Backhovens H, van Regenmorter N, Martin JJ, Van Broeckhoven C. Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:177–86.</span> [<a href="/pubmed/9425224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.enevoldson.1994.445">Enevoldson TP, Sanders MD, Harding AE. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. <span><span class="ref-journal">Brain. </span>1994;<span class="ref-vol">117</span>:445–60.</span> [<a href="/pubmed/8032856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8032856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.filla.2000.31">Filla A, Mariotti C, Caruso G, Coppola G, Cocozza S, Castaldo I, Calabrese O, Salvatore E, De Michele G, Riggio MC, Pareyson D, Gellera C, Di Donato S. Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families. <span><span class="ref-journal">Eur Neurol. </span>2000;<span class="ref-vol">44</span>:31–6.</span> [<a href="/pubmed/10894992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10894992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.fu.1991.1047">Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST, Oostra BA, Nelson DL, Thomas Caskey C. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. <span><span class="ref-journal">Cell. </span>1991;<span class="ref-vol">67</span>:1047–58.</span> [<a href="/pubmed/1760838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1760838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.furrer.2011.16269">Furrer SA, Mohanachandran MS, Waldherr SM, Chang C, Damian VA, Sopher BL, Garden GA, La Spada AR. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration. <span><span class="ref-journal">J Neurosci. </span>2011;<span class="ref-vol">31</span>:16269–78.</span> [<a href="/pmc/articles/PMC3256125/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3256125</span></a>] [<a href="/pubmed/22072678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22072678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.furrer.2013.890">Furrer SA, Waldherr SM, Mohanachandran MS, Baughn TD, Nguyen KT, Sopher BL, Damian VA, Garden GA, La Spada AR. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:890–903.</span> [<a href="/pmc/articles/PMC3561911/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3561911</span></a>] [<a href="/pubmed/23197655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23197655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.garden.2008.138">Garden GA, La Spada AR. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration. <span><span class="ref-journal">Cerebellum. </span>2008;<span class="ref-vol">7</span>:138–49.</span> [<a href="/pmc/articles/PMC4195584/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4195584</span></a>] [<a href="/pubmed/18418675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18418675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.garden.2002.4897">Garden GA, Libby RT, Fu YH, Kinoshita Y, Huang J, Possin DE, Smith AC, Martinez RA, Fine GC, Grote SK, Ware CB, Einum DD, Morrison RS, Ptacek LJ, Sopher BL, La Spada AR. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. <span><span class="ref-journal">J Neurosci. </span>2002;<span class="ref-vol">22</span>:4897–905.</span> [<a href="/pmc/articles/PMC6757746/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6757746</span></a>] [<a href="/pubmed/12077187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12077187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.giunti.1999.1594">Giunti P, Stevanin G, Worth PF, David G, Brice A, Wood NW. Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:1594–603.</span> [<a href="/pmc/articles/PMC1377902/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377902</span></a>] [<a href="/pubmed/10330346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10330346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.gouw.1998.525">Gouw LG, Casta&#x000f1;eda MA, McKenna CK, Digre KB, Pulst SM, Perlman S, Lee MS, Gomez C, Fischbeck K, Gagnon D, Storey E, Bird T, Jeri FR, Pt&#x000e1;cek LJ. Analysis of the dynamic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:525–32.</span> [<a href="/pubmed/9467013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9467013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.gouw.1994.1441">Gouw LG, Digre KB, Harris CP, Haines JH, Ptacek LJ. Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic, and genetic analysis of a large kindred. <span><span class="ref-journal">Neurology. </span>1994;<span class="ref-vol">44</span>:1441–7.</span> [<a href="/pubmed/8058146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8058146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.gu.2000.1513">Gu W, Wang Y, Liu X, Zhou B, Zhou Y, Wang G. Molecular and clinical study of spinocerebellar ataxia type 7 in Chinese kindreds. <span><span class="ref-journal">Arch Neurol. </span>2000;<span class="ref-vol">57</span>:1513–8.</span> [<a href="/pubmed/11030806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11030806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.han.2010a.622">Han Y, Deng B, Liu M, Jiang J, Wu S, Guan Y. Clinical and genetic study of a Chinese family with spinocerebellar ataxia type 7. <span><span class="ref-journal">Neurol India. </span>2010a;<span class="ref-vol">58</span>:622–6.</span> [<a href="/pubmed/20739808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20739808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.han.2010b.2274">Han Y, Yu L, Zheng HM, Guan YT. Clinical and genetic study of spinocerebellar ataxia type 7 in East Asian population. <span><span class="ref-journal">Chin Med J (Engl). </span>2010b;<span class="ref-vol">123</span>:2274–8.</span> [<a href="/pubmed/20819679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20819679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.harper.1990.1205">Harper PS, Clarke A. Should we test children for "adult" genetic diseases? <span><span class="ref-journal">Lancet. </span>1990;<span class="ref-vol">335</span>:1205–6.</span> [<a href="/pubmed/1971046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1971046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.havener.1951.40">Havener WH. Cerebellar-macular abiotrophy. <span><span class="ref-journal">AMA Arch Ophthalmol. </span>1951;<span class="ref-vol">45</span>:40–3.</span> [<a href="/pubmed/14789289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14789289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.hugosson.2009.1">Hugosson T, Gr&#x000e4;nse L, Ponjavic V, Andr&#x000e9;asson S. Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7). <span><span class="ref-journal">Ophthalmic Genet. </span>2009;<span class="ref-vol">30</span>:1–6.</span> [<a href="/pubmed/19172503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19172503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.illarioshkin.1996.506">Illarioshkin SN, Slominsky PA, Ovchinnikov IV, Markova ED, Miklina NI, Klyushnikov SA, Shadrina M, Vereshchagin NV, Limborskaya SA, Ivanova-Smolenskaya IA. Spinocerebellar ataxia type 1 in Russia. <span><span class="ref-journal">J Neurol. </span>1996;<span class="ref-vol">243</span>:506–10.</span> [<a href="/pubmed/8836939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8836939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.janer.2010.181">Janer A, Werner A, Takahashi-Fujigasaki J, Daret A, Fujigasaki H, Takada K, Duyckaerts C, Brice A, Dejean A, Sittler A. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:181–95.</span> [<a href="/pubmed/19843541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19843541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.jardim.2001.870">Jardim LB, Silveira I, Pereira ML, Ferro A, Alonso I, do C&#x000e9;u Moreira M, Mendon&#x000e7;a P, Ferreirinha F, Sequeiros J, Giugliani R. A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations. <span><span class="ref-journal">J Neurol. </span>2001;<span class="ref-vol">248</span>:870–6.</span> [<a href="/pubmed/11697524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11697524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.kim.2001.336">Kim JY, Park SS, Joo SI, Kim JM, Jeon BS. Molecular analysis of Spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7. <span><span class="ref-journal">Mol Cells. </span>2001;<span class="ref-vol">12</span>:336–41.</span> [<a href="/pubmed/11804332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11804332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.koeppen.2005.62">Koeppen AH. The pathogenesis of spinocerebellar ataxia. <span><span class="ref-journal">Cerebellum. </span>2005;<span class="ref-vol">4</span>:62–73.</span> [<a href="/pubmed/15895563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15895563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.konigsmark.1970.227">Konigsmark BW, Weiner LP. The olivopontocerebellar atrophies: a review. <span><span class="ref-journal">Medicine (Baltimore). </span>1970;<span class="ref-vol">49</span>:227–41.</span> [<a href="/pubmed/4910986" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4910986</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.koob.1998.72">Koob MD, Benzow KA, Bird TD, Day JW, Moseley ML, Ranum LP. Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:72–5.</span> [<a href="/pubmed/9425905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.lebre.2003">Lebre AS, Stevanin G, Brice A. Spinocerebellar ataxia 7 (SCA7). In: Pulst SM, ed. <em>Genetics of Movement Disorders</em>. San Diego, CA: Academic Press. 2003:85-94.</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.martin.1994.277">Martin JJ, Van Regemorter N, Krols L, Brucher JM, de Barsy T, Szliwowski H, Evrard P, Ceuterick C, Tassignon MJ, Smet-Dieleman H, Willems PJ. On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. <span><span class="ref-journal">Acta Neuropathol. </span>1994;<span class="ref-vol">88</span>:277–86.</span> [<a href="/pubmed/7839819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7839819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.michalik.2004.2">Michalik A, Martin JJ, Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. <span><span class="ref-journal">Eur J Hum Genet. </span>2004;<span class="ref-vol">12</span>:2–15.</span> [<a href="/pubmed/14571264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14571264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.michalik.2003.r173">Michalik A, Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>(Spec No 2):R173–86.</span> [<a href="/pubmed/14504263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14504263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.miller.2009.180">Miller RC, Tewari A, Miller JA, Garbern J, Van Stavern GP. Neuro-ophthalmologic features of spinocerebellar ataxia type 7. <span><span class="ref-journal">J Neuroophthalmol. </span>2009;<span class="ref-vol">29</span>:180–6.</span> [<a href="/pubmed/19726938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19726938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.mittal.2005.155">Mittal U, Roy S, Jain S, Srivastava AK, Mukerji M. Post-zygotic de novo trinucleotide repeat expansion at spinocerebellar ataxia type 7 locus: evidence from an Indian family. <span><span class="ref-journal">J Hum Genet. </span>2005;<span class="ref-vol">50</span>:155–7.</span> [<a href="/pubmed/15750685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15750685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.mookerjee.2009.15134">Mookerjee S, Papanikolaou T, Guyenet SJ, Sampath V, Lin A, Vitelli C, DeGiacomo F, Sopher BL, Chen SF, La Spada AR, Ellerby LM. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment. <span><span class="ref-journal">J Neurosci. </span>2009;<span class="ref-vol">29</span>:15134–44.</span> [<a href="/pmc/articles/PMC2907146/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2907146</span></a>] [<a href="/pubmed/19955365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19955365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.nakamura.2012.1099">Nakamura Y, Tagawa K, Oka T, Sasabe T, Ito H, Shiwaku H, La Spada AR, Okazawa H. Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:1099–110.</span> [<a href="/pmc/articles/PMC3277310/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3277310</span></a>] [<a href="/pubmed/22100762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22100762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.nardacchione.1999.232">Nardacchione A, Orsi L, Brusco A, Franco A, Grosso E, Dragone E, Mortara P, Schiffer D, De Marchi M. Definition of the smallest pathological CAG expansion in SCA7. <span><span class="ref-journal">Clin Genet. </span>1999;<span class="ref-vol">56</span>:232–4.</span> [<a href="/pubmed/10563484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10563484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.r_b.2008.155">R&#x000fc;b U, Brunt ER, Seidel K, Gierga K, Mooy CM, Kettner M, Van Broeckhoven C, Bechmann I, La Spada AR, Sch&#x000f6;ls L, den Dunnen W, de Vos RA, Deller T. Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments. <span><span class="ref-journal">Neuropathol Appl Neurobiol. </span>2008;<span class="ref-vol">34</span>:155–68.</span> [<a href="/pubmed/17971076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17971076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.sasaki.2000.45">Sasaki H, Yabe I, Yamashita I, Tashiro K. Prevalence of triplet repeat expansion in ataxia patients from Hokkaido, the northernmost island of Japan. <span><span class="ref-journal">J Neurol Sci. </span>2000;<span class="ref-vol">175</span>:45–51.</span> [<a href="/pubmed/10785256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10785256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.scholefield.2009.e7232">Scholefield J, Greenberg LJ, Weinberg MS, Arbuthnot PB, Abdelgany A, Wood MJ. Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e7232.</span> [<a href="/pmc/articles/PMC2747278/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2747278</span></a>] [<a href="/pubmed/19789634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19789634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.seidel.2012.1">Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, R&#x000fc;b U. Brain pathology of spinocerebellar ataxias. <span><span class="ref-journal">Acta Neuropathol. </span>2012;<span class="ref-vol">124</span>:1–21.</span> [<a href="/pubmed/22684686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22684686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.sokolovsky.2010.17">Sokolovsky N, Cook A, Hunt H, Giunti P, Cipolotti L. A preliminary characterisation of cognition and social cognition in spinocerebellar ataxia types 2, 1, and 7. <span><span class="ref-journal">Behav Neurol. </span>2010;<span class="ref-vol">23</span>:17–29.</span> [<a href="/pmc/articles/PMC5434399/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5434399</span></a>] [<a href="/pubmed/20714058" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20714058</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.sopher.2011.1071">Sopher BL, Ladd PD, Pineda VV, Libby RT, Sunkin SM, Hurley JB, Thienes CP, Gaasterland T, Filippova GN, La Spada AR. CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. <span><span class="ref-journal">Neuron. </span>2011;<span class="ref-vol">70</span>:1071–84.</span> [<a href="/pmc/articles/PMC3139428/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3139428</span></a>] [<a href="/pubmed/21689595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21689595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.stevanin.1998.1809">Stevanin G, Giunti P, Belal GD, D&#x000fc;rr A, Ruberg M, Wood N, Brice A. De novo expansion of intermediate alleles in spinocerebellar ataxia 7. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:1809–13.</span> [<a href="/pubmed/9736784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9736784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.storey.2000.351">Storey E, du Sart D, Shaw JH, Lorentzos P, Kelly L, McKinley Gardner RJ, Forrest SM, Biros I, Nicholson GA. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">95</span>:351–7.</span> [<a href="/pubmed/11186889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11186889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.tang.2000.540">Tang B, Liu C, Shen L, Dai H, Pan Q, Jing L, Ouyang S, Xia J. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. <span><span class="ref-journal">Arch Neurol. </span>2000;<span class="ref-vol">57</span>:540–4.</span> [<a href="/pubmed/10768629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10768629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.thurtell.2009.187">Thurtell MJ, Fraser JA, Bala E, Tomsak RL, Biousse V, Leigh RJ, Newman NJ. Two patients with spinocerebellar ataxia type 7 presenting with profound binocular visual loss yet minimal ophthalmoscopic findings. <span><span class="ref-journal">J Neuroophthalmol. </span>2009;<span class="ref-vol">29</span>:187–91.</span> [<a href="/pmc/articles/PMC2987707/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987707</span></a>] [<a href="/pubmed/19726939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19726939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.to.1993.15">To KW, Adamian M, Jakobiec FA, Berson EL. Olivopontocerebellar atrophy with retinal degeneration. An electroretinographic and histopathologic investigation. <span><span class="ref-journal">Ophthalmology. </span>1993;<span class="ref-vol">100</span>:15–23.</span> [<a href="/pubmed/8433819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8433819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.trottier.1995.403">Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L, Yves Agid Y, Brice A, Mandel J. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. <span><span class="ref-journal">Nature. </span>1995;<span class="ref-vol">378</span>:403–6.</span> [<a href="/pubmed/7477379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7477379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.tsai.2004.355">Tsai HF, Liu CS, Leu TM, Wen FC, Lin SJ, Liu CC, Yang DK, Li C, Hsieh M. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. <span><span class="ref-journal">Acta Neurol Scand. </span>2004;<span class="ref-vol">109</span>:355–60.</span> [<a href="/pubmed/15080863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15080863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.van_de_warrenburg.2001.911">van de Warrenburg BP, Frenken CW, Ausems MG, Kleefstra T, Sinke RJ, Knoers NV, Kremer HP. Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype. <span><span class="ref-journal">J Neurol. </span>2001;<span class="ref-vol">248</span>:911–4.</span> [<a href="/pubmed/11697534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11697534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.weiner.1967.364">Weiner LP, Konigsmark BW, Stoll J Jr, Magladery JW. Hereditary olivopontocerebellar atrophy with retinal degeneration. Report of a family through six generations. <span><span class="ref-journal">Arch Neurol. </span>1967;<span class="ref-vol">16</span>:364–76.</span> [<a href="/pubmed/6021917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6021917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca7.REF.yvert.2000.2491">Yvert G, Lindenberg KS, Picaud S, Landwehrmeyer GB, Sahel JA, Mandel JL. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:2491–506.</span> [<a href="/pubmed/11030754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11030754</span></a>]</div></li></ul></div></div><div id="sca7.Chapter_Notes"><h2 id="_sca7_Chapter_Notes_">Chapter Notes</h2><div id="sca7.Author_History"><h3>Author History</h3><p>Thomas D Bird, MD; University of Washington (2007-2012) <br />Gwenn Garden, MD, PhD (2012-present)<br />Launce G-C Gouw, MD, PhD; University of Utah School of Medicine (1998-2007) <br />Albert R La Spada, MD, PhD; University of California, San Diego (2007-2012) <br />Roberta A Pagon, MD; University of Washington (2007-2012) <br />Louis J Ptacek, MD; University of California at San Francisco (1998-2007)</p></div><div id="sca7.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>20 December 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 September 2007 (tb) Revision: Natural History (Clinical Description)</div></li><li class="half_rhythm"><div>9 February 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 December 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 June 2001 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 August 1998 (pb) Review posted live</div></li><li class="half_rhythm"><div>1 June 1998 (lg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1256</span><span class="label">PMID: <a href="/pubmed/20301433" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301433</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca6/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca8/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1256&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1256/?report=reader">PubReader</a></li><li><a href="/books/NBK1256/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1256" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1256" style="display:none" title="Cite this Page"><div class="bk_tt">Garden G. Spinocerebellar Ataxia Type 7. 1998 Aug 27 [Updated 2012 Dec 20]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1256/pdf/Bookshelf_NBK1256.pdf">PDF version of this page</a> (479K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sca7.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sca7.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sca7.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sca7.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sca7.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sca7.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sca7.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sca7.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sca7.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sca7.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sca7.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6314[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATXN7</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1498258" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1498258" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1498258" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1498258" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301363" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Opal P, Ashizawa T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301452" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pulst SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301445" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 8</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 8<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ayhan F, Ikeda Y, Dalton JC, Day JW, Ranum LPW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301573" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 14</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 14<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen DH, Bird TD, Raskind WH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301375" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 3</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 3<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Paulson H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301433" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301433" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041653dd21425a25195e06">Spinocerebellar Ataxia Type 7 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spinocerebellar Ataxia Type 7 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:09:23-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE8819D0E041148100000000023800E7&amp;ncbi_session=CE8819D0E0416521_0568SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1256%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1256&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1256/&amp;ncbi_pagename=Spinocerebellar Ataxia Type 7 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8819D0E0416521_0568SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>